Summary

This episode wraps up the coverage of the ISOPP CAPhO 2025 symposium, highlighting key sessions from the final day. It covers clinical updates in lung and urothelial cancers, innovative approaches in cancer care, the capacity crisis in cancer services, the expanding roles of pharmacists and technicians, and innovative models of care in breast cancer. The discussion emphasizes the importance of proactive management, patient-centered care, and the integration of technology in oncology pharmacy practice.

Eoin Tabb reports from Day 3 of the ISOPP CAPhO 2025 Symposium in Victoria, Canada. This episode delves into crucial discussions on Equity, Diversity, and Inclusion (EDI) in pharmacy practice, the benefits and risks of Artificial Intelligence (AI) in oncology, updates on preventing Cancer-Associated Thrombosis (CAT), and the implementation of pre-therapeutic Pharmacogenomics (PGx), including combining DPYD testing with Therapeutic Drug Monitoring (TDM) for 5-FU.

Plus, hear exciting news from the ISOPP AGM about next year's unique 24-hour virtual conference format and a special collaboration with the Irish Pharmacy Haematology Oncology Society (IPHOS)!

#ISOPPCAPhO2025 #OncologyPharmacy #Haematology #ClinicalPharmacy #EDI #AI #PGx #TDM #CAT

CAT Survey: https://redcap.alfredhealth.org.au/redcap/surveys/index.php?s=dFo7DpNgVBauTYeW&__startover=1

Join Eoin Tabb for the second daily dispatch from the ISOPP CAPhO 2025 Symposium in Victoria, Canada. Day 2 covered a wide spectrum of crucial topics for haematology/oncology pharmacy practice.

Highlights include practical management strategies for PARP inhibitors, the importance of cultural humility and discussing traditional medicines, ISOPP's new global service level framework, pharmacy's role in disaster preparedness and environmental sustainability, efficiencies in myeloma treatment administration (pre-meds, infusion times, schedules), managing CMV infections, considerations for treating older/unfit patients using geriatric assessment, and critical updates on hazardous drug lists and safety.

Tune in for key insights and takeaways relevant to Irish practice!

#ISOPPCAPhO2025 #OncologyPharmacy #Haematology #ClinicalPharmacy

PARPi Clinical Resource: https://cdn.ymaws.com/www.cano-acio.ca/resource/resmgr/endorsements/en_parp_inhibitor_clinical_r.pdf

Join host Eoin Tabb for a special dispatch episode recorded live from the ISOPP 2025 Symposium in Victoria, BC. Get your 'audio delegate bag' with key insights from Day 1, covering:  

• Implementing bispecific antibodies (BiTEs) like teclistamab and talquetamab in multiple myeloma, focusing on community administration and managing toxicities (CRS, ICANS, infections, oral/skin/nail issues).  
• The practice-changing impact of blinatumomab in frontline B-ALL based on the E1910 trial.  
• Innovations in hazardous drug safety using Closed System Transfer Devices (CSTDs) and automation.  
• SMART strategies for managing toxicities (ILD, neutropenia, nausea, neuropathy) of ADCs like T-DXd, T-DM1, and Sacituzumab Govitecan in metastatic breast cancer.

Podcast Description:

Navigating the complexities of systemic anticancer therapy (SACT) demands meticulous attention to detail, especially when it comes to prescribing. In this episode of the Irish Haematology Oncology Podcast, join your host Eoin Tabb as he delves into the critical aspects of safe prescribing practices for SACT. We'll explore the reasons why SACT prescribing is considered high-risk, the essential steps involved in the prescribing process for both first and subsequent cycles, and the key components of a comprehensive treatment plan. We'll also discuss the legal requirements and prescribing standards, strategies to mitigate errors, and the unique safety challenges associated with oral anticancer medicines (OAMs). Whether you're at the beginning of your career or seeking a refresher, this episode will equip you with the knowledge and insights to ensure the safe and effective administration of these powerful medications to your patients.

Takeaways

Feedback Form

IIOP Example CPD for Pharmacists

Podcast Description:

Join Eoin Tabb on the Irish Haematology Oncology Podcast as he unravels the critical role of drug sequencing in cancer treatment. Discover how the order of drug administration can impact patient safety, treatment efficacy, and overall well-being. Learn about the dangers of extravasation and how to safely administer vesicant drugs. Explore real-world case studies and gain insights from clinical trials that have shaped our understanding of optimal treatment protocols. This episode is a must-listen for healthcare professionals seeking to enhance their knowledge and skills in oncology care.

Show Notes:

Relevant clinical trials and research studies as outlined in episode

Join us on the Irish Haematology Oncology Podcast as we delve into the critical topic of chemotherapy extravasation. We'll explore what it is, why it happens, and the potential consequences. More importantly, we'll discuss how to prevent it and effectively manage it if it occurs. Whether you're a seasoned healthcare professional or new to the field, this episode offers valuable insights to enhance patient safety and optimize cancer care.

Key Points:

Resources:

Feedback Form: https://forms.gle/DzC4ye9edfV4rMZF8

Join host Eoin Tabb on the Irish Haematology Oncology Podcast as he delves into the critical role of ancillary medications in chemotherapy. This episode focuses on essential supportive care drugs like vitamins, steroids, and hydration protocols, highlighting their mechanisms, administration, and importance in mitigating side effects and optimizing treatment outcomes. Learn about:

2. Podcast Show Notes:

Feedback Form: https://forms.gle/ctCHDcc7d4W4NfB18

IIOP Education Document (same as last episode): https://docs.google.com/document/d/1d1KEtJ6yrZ_fMGMLgTFgQ762rX0-y5vbb4ikDsr_U6s/edit?usp=sharing

Summary

This episode of the Irish Hematology Oncology podcast explores the importance of ancillary medications in chemotherapy regimens. The host discusses specific medications used to address the side effects and risks of chemotherapy drugs, including Pemetrexed with vitamin B12 and folic acid, Docetaxel with corticosteroids, Irinotecan with atropine, and 5-FU with leucovorin. Each medication is explained in detail, highlighting its role in managing side effects and enhancing the effectiveness of chemotherapy.

Takeaways

IIOP CPD Example: https://docs.google.com/document/d/1d1KEtJ6yrZ_fMGMLgTFgQ762rX0-y5vbb4ikDsr_U6s/edit?usp=sharing

Feedback Form: https://forms.gle/ortbvq6Ld19zSCDG7

Join Eoin Tabb on the Irish Haematology Oncology Podcast as he delves into the common skin reactions caused by cancer treatments. This episode is a must-listen for healthcare professionals seeking to enhance patient care by understanding, preventing, and managing these often-overlooked side effects. From acneiform rash to hand-foot syndrome, hair loss, drug-induced pruritus, paronychia, and onycholysis, Eoin breaks down the incidence, diagnosis, pathology, and treatment options for each condition. Gain valuable insights and practical tips to improve your patients' quality of life during their cancer journey. Tune in and empower yourself to make a real difference in your patients' well-being.

In this episode of the Irish Haematology Oncology Podcast, host Eoin Tabb discusses common skin reactions caused by cancer treatments. He covers the following topics:

Eoin emphasizes the importance of early intervention, open communication with patients, and tailoring treatment plans to individual needs. He also provides resources for further learning and encourages listeners to stay informed about the latest research and treatment options.

References:

Lacouture, M. E., Sibaud, V., Gerber, P. A., van den Hurk, C., Fernández-Peñas, P., Santini, D., ... & Jordan, K. (2021). Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines. Annals of Oncology, 32(2), 157-170.